Testing a new progesterone tablet for luteal phase issues
Part of Women’s health & pregnancy clinical trials.
This trial tests a new progesterone tablet (Callavid) to see if it is safe and easy to use for women with a short or weak luteal phase (the time after ovulation). It may help support early pregnancy and reduce the risk of miscarriage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 45 years old.
- You have had at least one miscarriage in the past.
- You have a condition called luteal phase insufficiency, which may cause spotting before your period, a very short time between ovulation and your period, or other symptoms of low progesterone.
- You are not currently pregnant or breastfeeding.
- You have no allergies to progesterone or similar hormone medications, and no history of conditions like breast cancer that prevent hormone treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the lining of the womb (the luteal phase) affects the placenta in early pregnancy. It aims to understand why some pregnancies have complications and may help improve care for future pregnancies.
This study looks at how progesterone levels change in the early part of the luteal phase (after ovulation) when ovulation is triggered by an hCG injection in a natural cycle. It may help women undergoing routine ovulation induction understand how their body responds.
This trial tests a hormone-releasing vaginal system for birth control in women who can become pregnant. It may help prevent pregnancy safely and effectively.
This trial tests a new contraceptive patch to see if it can prevent ovulation (the release of an egg). If you are a healthy woman looking for a non-hormonal birth control option, this study may be a good fit.
This study compares two ways to give progesterone to young people on estrogen replacement therapy to see how they affect the lining of the uterus. It will help find which approach may be safer and more effective for your health.
This study tests a new birth control pill to see how well it prevents pregnancy and if it's safe. It combines a lower dose of estrogen with a different type of progestogen that blocks male hormones.
Hear when a new Luteal Phase Insuffiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.